Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DIPHENYLHYDANTOIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 230 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tasso, SM; Bruno-Blanch, LE; Estiu, GL
      Pharmacophore model for antiepileptic drugs acting on sodium channels

      JOURNAL OF MOLECULAR MODELING
    2. Gungor, E; Alli, N; Comoglu, S; Comcuoglu, C
      Phenytoin hypersensitivity syndrome

      NEUROLOGICAL SCIENCES
    3. El-Mallakh, RS; Huff, MO
      Mood stabilizers and ion regulation

      HARVARD REVIEW OF PSYCHIATRY
    4. Eadie, MJ
      Therapeutic drug monitoring - antiepileptic drugs

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    5. Eralp, Y; Aydiner, A; Tas, F; Saip, P; Topuz, E
      Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    6. Nashed, MH; Liao, L
      Possible atypical cross-sensitivity between phenytoin and carbamazepine inthe anticonvulsant hypersensitivity syndrome

      PHARMACOTHERAPY
    7. Kaul, A; Kalla, NR; Goyle, S
      I. The modulatory effect in genotoxic responses due to age and duration ofPHT-therapy in epileptic patients

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    8. Kodama, H; Kodama, Y; Itokazu, N; Shinozawa, S; Kanemaru, R; Sugimoto, T
      Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    9. Learmonth, DA; Benes, J; Parada, A; Hainzl, D; Beliaev, A; Bonifacio, MJ; Matias, PM; Carrondo, RLA; Garrett, J; Soares-da-Silva, P
      Synthesis, anticonvulsant properties and pharmacokinetic profile of novel 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide derivatives

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    10. Desta, Z; Soukhova, NV; Flockhart, DA
      Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: Potent inhibition of CYP2C19 and CYP3A

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. Pryor, FM; Gidal, B; Ramsay, RE; DeToledo, J; Morgan, RO
      Fosphenytoin: Pharmacokinetics and tolerance of intramuscular loading doses

      EPILEPSIA
    12. Kodama, H; Kodama, Y; Itokazu, N; Arimori, K; Kanemaru, R; Sugimoto, T; Fujimura, A
      Effect of sex on serum protein binding characteristics of phenytoin in pediatric patients with epilepsy

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    13. Kodama, H; Kodama, Y; Shinozawa, S; Kanemaru, R; Itokazu, N; Sugimoto, T
      In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    14. Borowicz, KK; Kleinrok, Z; Czuczwar, SJ
      N-6-2-(4-Aminophenyl)ethyl-adenosine enhances the anticonvulsive action ofconventional antiepileptic drugs in the kindling model of epilepsy in rats

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    15. Schlienger, R; Kurmann, M; Drewe, J; Muller-Spahn, F; Seifritz, E
      Inhibition of phenprocoumon anticoagulation by carbamazepine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    16. Tripathi, M; Sundaram, R; Rafiq, M; Venkataranganna, MV; Gopumadhavan, S; Mitra, SK
      Pharmacokinetic interactions of Mentat with carbamazepine and phenytoin

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    17. Ciechanowicz-Rutkowska, M; Stadnicka, K; Kiec-Kononowicz, K; Byrtus, H; Filipek, B; Zygmunt, M; Maciag, D
      Structure-activity relationship of some new anti-arrhythmic phenytoin derivatives

      ARCHIV DER PHARMAZIE
    18. Fervenza, FC; Kanakiriya, S; Kunau, RT; Gibney, R; Lager, DJ
      Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment

      AMERICAN JOURNAL OF KIDNEY DISEASES
    19. Tripathi, M; Kaushik, S
      Carbamezapine for pain management in Guillain-Barre syndrome patients in the intensive cave unit

      CRITICAL CARE MEDICINE
    20. Denac, H; Mevissen, M; Scholtysik, G
      Structure, function and pharmacology of voltage-gated sodium channels

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    21. Burt, M; Anderson, DC; Kloss, J; Apple, FS
      Evidence-based implementation of free phenytoin therapeutic drug monitoring

      CLINICAL CHEMISTRY
    22. Camerman, A; Mastropaolo, D; Hempel, A; Camerman, N
      Hydrogen bonding interaction of diphenylbarbituric acid and 9-ethyladenine. Crystal structure of a 1 : 1 complex

      CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE
    23. Otoom, SA; Alkadhi, KA
      Action of carbamazepine on epileptiform activity of the verartidine model in CA1 neurons

      BRAIN RESEARCH
    24. Foster, SF; Church, DB; Watson, ADJ
      Effect of phenobarbitone on the low-dose dexamethasone suppression test and the urinary corticoid: creatinine ratio in dogs

      AUSTRALIAN VETERINARY JOURNAL
    25. Gutting, BW; Schomaker, SJ; Kaplan, AH; Amacher, DE
      A comparison of the direct and reporter antigen popliteal lymph node assayfor the detection of immunomodulation by low molecular weight compounds

      TOXICOLOGICAL SCIENCES
    26. Grech, V; Vella, C
      Atrioventricular septal defect with separate right and left atrioventricular valvar orifices in a patient with foetal hydantoin syndrome

      CARDIOLOGY IN THE YOUNG
    27. Pieters, R; Albers, R
      Assessment of autoimmunogenic potential of xenobiotics using the popliteallymph node assay

      METHODS-A COMPANION TO METHODS IN ENZYMOLOGY
    28. Vaillant, L
      Drug hypersensitivity syndrome: drug rash with eosinophilia and systemic symptoms (DRESS)

      JOURNAL OF DERMATOLOGICAL TREATMENT
    29. Berry, JM; Kowalski, A; Fletcher, SA
      Sudden asystole during craniotomy: Unrecognized phenytoin toxicity

      JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY
    30. Schilling, MA; Inman, SL; Morford, LL; Moran, MS; Vorhees, CV
      Prenatal phenytoin exposure and spatial navigation in offspring: Effects on reference and working memory and on discrimination learning

      NEUROTOXICOLOGY AND TERATOLOGY
    31. McCartney, MA; Scinto, PL; Wang, SS; Altan, S
      Developmental effects of phenytoin may differ depending on sex of offspring

      NEUROTOXICOLOGY AND TERATOLOGY
    32. Hatta, T; Ohmori, H; Murakami, T; Takano, M; Yamashita, K; Yasuda, M
      Neurotoxic effects of phenytoin on postnatal mouse brain development following neonatal administration

      NEUROTOXICOLOGY AND TERATOLOGY
    33. Tunnicliff, G
      Actions of sodium valproate on the central nervous system

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    34. Asakawa, T; Inoue, K; Yoshizuka, K; Ohto, K
      Solvent extraction of silver with 5,5-diphenyl-2, 4-imidazolidinedione

      KAGAKU KOGAKU RONBUNSHU
    35. Malhotra, J; Gupta, YK
      Effect of adenosinergic modulation on the anticonvulsant effect of phenobarbitone and carbamazepine

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    36. Crowson, AN; Magro, CM
      Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy

      JOURNAL OF CUTANEOUS PATHOLOGY
    37. Marik, P
      Anticonvulsant hypersensitivity syndrome occurring as sepsis with multiorgan dysfunction

      PHARMACOTHERAPY
    38. Kaul, A; Goyle, S
      Genotoxicity of the anticonvulsant drug phenytoin (PHT): A follow-up studyof PHT-untreated epileptic patients. I. Sister chromatid exchange (SCE) analysis

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    39. Fedler, C; Stewart, MJ
      Plasma total phenytoin: A possibly misleading test in developing countries

      THERAPEUTIC DRUG MONITORING
    40. Albers, R; van der Pijl, A; Bol, M; Bleumink, R; Seinen, W; Pieters, R
      Distinct immunomodulation by autoimmunogenic xenobiotics in susceptible and resistant mice

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    41. Mahadeva, U; Al-Mrayat, M; Steer, K; Leen, E
      Fatal phenytoin hypersensitivity syndrome

      POSTGRADUATE MEDICAL JOURNAL
    42. Stella, VJ; Martodihardjo, S; Rao, VM
      Aqueous solubility and dissolution rate does not adequately predict in vivo performance: A probe utilizing some N-acyloxymethyl phenytoin prodrugs

      JOURNAL OF PHARMACEUTICAL SCIENCES
    43. Kamali, F; Ball, DE; McLaughlin, WS; Seymour, RA
      Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth

      JOURNAL OF PERIODONTAL RESEARCH
    44. Brown, ML; Zha, CC; Van Dyke, CC; Brown, GB; Brouillette, WJ
      Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel

      JOURNAL OF MEDICINAL CHEMISTRY
    45. Benes, J; Parada, A; Figueiredo, AA; Alves, PC; Freitas, AP; Learmonth, DA; Cunha, RA; Garrett, J; Soares-da-Silva, P
      Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives

      JOURNAL OF MEDICINAL CHEMISTRY
    46. Amano, K; Takamatsu, J; Ogata, A; Katsuragi, S; Miyazaki, C; Deshimaru, M; Sumiyoshi, S; Miyakawa, T
      Effect of dipotassium clorazepate on amygdaloid-kindling and comparison between amygdaloid- and hippocampal-kindled seizures in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    47. Zhou, J; He, XW; Li, YJ
      Binding study on 5,5-diphenylhydantoin imprinted polymer constructed by utilizing an amide functional group

      ANALYTICA CHIMICA ACTA
    48. JIMENEZ MC; DURAN JA; ABADIN JA
      FACTORS AFFECTING THE FREE PLASMA FRACTION OF PHENYTOIN IN PATIENTS WITH EPILEPSY

      Clinical drug investigation
    49. Morton, LD; Pellock, JM
      Treatment options for acute seizure care - Use of new formulations

      CNS DRUGS
    50. BONILLA PAG; AGUILERA GR; BRITO FF; TORRIJOS EG; RODRIGUEZ RG; DELACALLE PC; BARRIOS CE
      PHENYTOIN HYPERSENSITIVITY SYNDROME WITH POSITIVE PATCH TEST - A POSSIBLE CROSS-REACTIVITY WITH AMITRIPTYLINE

      Journal of investigational allergology & clinical immunology
    51. THOMAS SV; ALEXANDER A; PADMANABHAN V; SARMA PS
      NEUROPSYCHOLOGICAL IMPAIRMENT AND ALTERED THYROID-HORMONE LEVELS IN EPILEPSY

      National Medical Journal of India
    52. LOSCHER W; CRAMER S; EBERT U
      LIMBIC EPILEPTOGENESIS ALTERS THE ANTICONVULSANT EFFICACY OF PHENYTOIN IN SPRAGUE-DAWLEY RATS

      Epilepsy research
    53. POLMAN AJ; VANDERWERF TS; TIEBOSCH ATMC; ZIJLSTRA JG
      EARLY-ONSET PHENYTOIN TOXICITY MIMICKING A RENOPULMONARY SYNDROME

      The European respiratory journal
    54. TSUTSUMI S; AKAIKE M; OHNO H; KATO N
      LEARNING MEMORY IMPAIRMENTS IN RAT OFFSPRING PRENATALLY EXPOSED TO PHENYTOIN/

      Neurotoxicology and teratology
    55. WHELESS JW
      PEDIATRIC USE OF INTRAVENOUS AND INTRAMUSCULAR PHENYTOIN - LESSONS LEARNED

      Journal of child neurology
    56. KRSEK P; HAUGVICOVA R; MARES P
      AGE-DEPENDENT PHENYTOIN EFFECTS ON CORTICAL STIMULATION IN RATS

      Physiologia bohemoslovaca
    57. EADIE MJ
      THERAPEUTIC DRUG-MONITORING - ANTIEPILEPTIC DRUGS

      British journal of clinical pharmacology
    58. SASAKI T; MAITA E
      INCREASED BFGF LEVEL IN THE SERUM OF PATIENTS WITH PHENYTOIN-INDUCED GINGIVAL OVERGROWTH

      Journal of clinical periodontology
    59. KAMINSKI R; PRZYWARA B; GASIOR M; KLEINROK Z; CZUCZWAR SJ
      EFFECT OF 5-FLUOROINDOLE-2-CARBOXYLIC ACID (AN ANTAGONIST OF THE NMDARECEPTOR-ASSOCIATED GLYCINE SITE) ON THE ANTICONVULSIVE ACTIVITY OF CONVENTIONAL ANTIEPILEPTIC DRUGS

      Journal of neural transmission
    60. PITNER JK; LONG LD; MEYER RP; PENNYPACKER LC
      PHENYTOIN TOXICITY IN AN OLDER PATIENT WITH SLOW METABOLISM AND ATYPICAL PRESENTATION

      Pharmacotherapy
    61. TAN L; HUGER FP; KLEIN JT; DAVIS L; MARTIN LL; SHIMSHOCK S; EFFLAND RC; SMITH CP; KONGSAMUT S
      4-AMINOPYRIDINE DERIVATIVES - A FAMILY OF NOVEL MODULATORS OF VOLTAGE-DEPENDENT SODIUM-CHANNELS

      Drug development research
    62. Kodama, H; Kodama, Y; Shinozawa, S; Kanemaru, R; Todaka, K; Mitsuyama, Y
      Serum protein binding kinetics of phenytoin in monotherapy patients

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    63. GLORIA L; SEREJO F; CRUZ E; FREITAS J; COSTA A; RAMALHO F; BATISTA A; DEMOURA MC
      DIPHENYLHYDANTOIN-INDUCED HEPATITIS - A CASE-REPORT

      Hepato-gastroenterology
    64. DASGUPTA A; HAVLIK D
      ELEVATED FREE FOSPHENYTOIN CONCENTRATIONS IN UREMIC SERA - UREMIC TOXINS HIPPURIC-ACID AND INDOXYL SULFATE DO NOT ACCOUNT FOR THE IMPAIRED PROTEIN-BINDING OF FOSPHENYTOIN

      Therapeutic drug monitoring
    65. LUER MS
      FOSPHENYTOIN

      Neurological research
    66. Coletta, RD; Almeida, OP; Graner, E; Page, RC; Bozzo, L
      Differential proliferation of fibroblasts cultured from hereditary gingival fibromatosis and normal gingiva

      JOURNAL OF PERIODONTAL RESEARCH
    67. BOSI G; EVANGELISTI R; VALENO V; CARINCI F; PEZZETTI F; CALASTRINI C; BODO M; CARINCI P
      DIPHENYLHYDANTOIN AFFECTS GLYCOSAMINOGLYCANS AND COLLAGEN PRODUCTION BY HUMAN FIBROBLASTS FROM CLEFT-PALATE PATIENTS

      Journal of dental research
    68. KRUG M; BECKER A; GRECKSCH G; PFEIFFER A; MATTHIES R; WAGNER M
      EFFECTS OF ANTICONVULSIVE DRUGS ON PENTYLENETETRAZOL KINDLING AND LONG-TERM POTENTIATION IN FREELY MOVING RATS

      European journal of pharmacology
    69. VOSKUYL RA; VREUGDENHIL M; KANG JX; LEAF A
      ANTICONVULSANT EFFECT OF POLYUNSATURATED FATTY-ACIDS IN RATS, USING THE CORTICAL STIMULATION MODEL

      European journal of pharmacology
    70. ALBUS H; WILLIAMSON R
      ELECTROPHYSIOLOGIC ANALYSIS OF THE ACTIONS OF VALPROATE ON PYRAMIDAL NEURONS IN THE RAT HIPPOCAMPAL SLICE

      Epilepsia
    71. KUGLER AR; ANNESLEY TM; NORDBLOM GD; KOUP JR; OLSON SC
      CROSS-REACTIVITY OF FOSPHENYTOIN IN 2 HUMAN PLASMA PHENYTOIN IMMUNOASSAYS

      Clinical chemistry
    72. KOUNO Y; ISHIKURA C; HOMMA M; OKA K
      EXTRASHOT-ODS, A SYRINGE-TYPE MINICOLUMN SAMPLE INJECTOR FOR A REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC COLUMN - APPLICATION TO ANTIEPILEPTICS IN HUMAN SERA

      Journal of chromatography B. Biomedical sciences and applications
    73. KLEINPETER E
      THE STRUCTURE OF HYDANTOINS IN SOLUTION AND IN THE SOLID-STATE

      Structural chemistry
    74. FURUE H; FUDAMATO N; OHTUBO Y; YOSHII K
      PHENYTOIN PROTECTED MOUSE CORTICAL CELL-CULTURES AGAINST NEUROTOXICITY INDUCED BY KAINATE BUT NOT BY NMDA

      Amino acids
    75. MAVROUDAKIS N; CAROYER JM; BRUNKO E; DEBEYL DZ
      EFFECTS OF VIGABATRIN ON MOTOR POTENTIALS-EVOKED WITH MAGNETIC STIMULATION

      ELECTROMYOGRAPHY AND MOTOR CONTROL-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY
    76. RAMSAY RE; WILDER BJ; UTHMAN BM; GARNETT WR; PELLOCK JM; BARKLEY GL; LEPPIK IE; KNAPP LE
      INTRAMUSCULAR FOSPHENYTOIN (CEREBYX(R)) IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN

      Epilepsy research
    77. OKADA M; KAWATA Y; KIRYU K; MIZUNO K; WADA K; INOMATA H; TASAKI H; KANEKO S
      EFFECTS OF NONTOXIC AND TOXIC CONCENTRATIONS OF PHENYTOIN ON MONOAMINES LEVELS IN RAT-BRAIN

      Epilepsy research
    78. BAUMGARTNER A; PINNA G; HIEDRA L; GAIO U; HESSENIUS C; CAMPOSBARROS A; ERAVCI M; PRENGEL H; THOMA R; MEINHOLD H
      EFFECTS OF LITHIUM AND CARBAMAZEPINE ON THYROID-HORMONE METABOLISM INRAT-BRAIN

      Neuropsychopharmacology
    79. WHITING S; CAMFIELD P; ARAB D; SALISBURY S
      INSULIN-DEPENDENT DIABETES-MELLITUS PRESENTING IN CHILDREN AS FREQUENT, MEDICALLY UNRESPONSIVE, PARTIAL SEIZURES

      Journal of child neurology
    80. SCHRODERVANDERELST JP; VANDERHEIDE D; DISTEFANO J; VANDERBENT C; KAPTEIN E; VISSER TJ
      EFFECTS OF 5,5'-DIPHENYLHYDANTOIN ON THE METABOLIC PATHWAY OF THYROID-HORMONE IN RATS

      European journal of endocrinology
    81. TAGAWA T; SUMI K; UNO R; ITAGAKI Y; FUJII F; YAMAGUCHI H
      PURE RED-CELL APLASIA DURING CARBAMAZEPINE MONOTHERAPY

      Brain & development
    82. CHAN E
      SINGLE-POINT PHENYTOIN DOSAGE PREDICTIONS IN SINGAPORE CHINESE

      Journal of clinical pharmacy and therapeutics
    83. CHENG LL; WANG SJ; TSAI JJ; GEAN PW
      EFFECTS OF PHENYTOIN ON THE AMYGDALA NEURONS IN-VITRO

      Pharmacology
    84. EBERT U; CRAMER S; LOSCHER W
      PHENYTOINS EFFECT ON THE SPREAD OF SEIZURE ACTIVITY IN THE AMYGDALA KINDLING MODEL

      Naunyn-Schmiedeberg's archives of pharmacology
    85. KUO CC; CHEN RS; LU L; CHEN RC
      CARBAMAZEPINE INHIBITION OF NEURONAL NA- QUANTITATIVE DISTINCTION FROM PHENYTOIN AND POSSIBLE THERAPEUTIC IMPLICATIONS( CURRENTS )

      Molecular pharmacology
    86. KIM PM; WINN LM; PARMAN T; WELLS PG
      UDP-GLUCURONOSYLTRANSFERASE-MEDIATED PROTECTION AGAINST IN-VITRO DNA OXIDATION AND MICRONUCLEUS FORMATION INITIATED BY PHENYTOIN AND ITS EMBRYOTOXIC METABOLITE 5-(P-HYDROXYPHENYL)-5-PHENYLHYDANTOIN

      The Journal of pharmacology and experimental therapeutics
    87. DILL RE; IACOPINO AM
      MYOFIBROBLASTS IN PHENYTOIN-INDUCED HYPERPLASTIC CONNECTIVE-TISSUE INTHE RAT AND IN HUMAN GINGIVAL OVERGROWTH

      Journal of periodontology
    88. YAMAMOTO R; YANAGITA T; KOBAYASHI H; YOKOO H; WADA A
      UP-REGULATION OF SODIUM-CHANNEL SUBUNIT MESSENGER-RNAS AND THEIR CELL-SURFACE EXPRESSION BY ANTIEPILEPTIC VALPROIC ACID - ACTIVATION OF CALCIUM-CHANNEL AND CATECHOLAMINE SECRETION IN ADRENAL CHROMAFFIN CELLS

      Journal of neurochemistry
    89. BROWN ML; BROWN GB; BROUILLETTE WJ
      EFFECTS OF LOG-P AND PHENYL RING CONFORMATION ON THE BINDING OF 5-PHENYLHYDANTOINS TO THE VOLTAGE-DEPENDENT SODIUM-CHANNEL

      Journal of medicinal chemistry
    90. PAVIA MA; BAIER B; NOLI MI; HAGMULLER K; ZANINOVICH AA
      EVIDENCE SUGGESTING THAT CADMIUM INDUCES A NONTHYROIDAL ILLNESS SYNDROME IN THE RAT

      Journal of Endocrinology
    91. BOROWICZ KK; KLEINROK Z; CZUCZWAR SJ
      N-6-2-(4-AMINOPHENYL)ETHYL-ADENOSINE ENHANCES THE ANTICONVULSIVE ACTIVITY OF ANTIEPILEPTIC DRUGS

      European journal of pharmacology
    92. OLSEN AK; HANSEN KT; FRIIS C
      PIG HEPATOCYTES AS AN IN-VITRO MODEL TO STUDY THE REGULATION OF HUMANCYP3A4 - PREDICTION OF DRUG-DRUG INTERACTIONS WITH 17-ALPHA-ETHYNYLESTRADIOL

      Chemico-biological interactions
    93. MURRAY JC; HILL RM; HEGEMIER S; HURWITZ RL
      LYMPHOBLASTIC LYMPHOMA FOLLOWING PRENATAL EXPOSURE TO PHENYTOIN

      Journal of pediatric hematology/oncology
    94. ANSTEAD GM; HART LM; SUNAHARA JF; LITER ME
      PHENYTOIN IN WOUND-HEALING

      The Annals of pharmacotherapy
    95. MARKOWSKY SJ; SKAAR DJ; CHRISTIE JM; EYER SD; EHRESMAN DJ
      PHENYTOIN PROTEIN-BINDING AND DOSAGE REQUIREMENTS DURING ACUTE AND CONVALESCENT PHASES FOLLOWING BRAIN INJURY

      The Annals of pharmacotherapy
    96. FERN R; RANSOM BR; WAXMAN SG
      AUTOPROTECTIVE MECHANISMS IN THE CNS - SOME NEW LESSONS FROM WHITE-MATTER

      Molecular and chemical neuropathology
    97. GRIFFIN JP
      DRUG-INTERACTIONS WITH AGENTS USED IN THE TREATMENT OF EPILEPSY

      Adverse drug reactions and toxicological reviews
    98. LEPPIK IE
      RATIONAL MONOTHERAPY FOR EPILEPSY

      Bailliere's clinical neurology
    99. DETHLOFF LA; GRAZIANO MJ; GOLDENTHAL E; GOUGH A; DELAIGLESIA FA
      PERSPECTIVE ON THE CARCINOGENIC POTENTIAL OF PHENYTOIN BASED ON RODENT TUMOR BIOASSAYS AND HUMAN EPIDEMIOLOGIC DATA

      Human & experimental toxicology
    100. SONG JH; NAGATA K; HUANG CS; YEH JZ; NARAHASHI T
      DIFFERENTIAL BLOCK OF 2 TYPES OF SODIUM-CHANNELS BY ANTICONVULSANTS

      NeuroReport


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 17:31:42